Join LLS partner, nbmtLINK for their upcoming Lunch & Learn with the LINK, Mindfulness in the New Year on Wednesday, January 27 at noon EST. Our professional speaker, Ailey Armstrong, an Oncology Social Worker, MSW, LICSW at SCCA will share how mindfulness is a set of psychological skills for effective living that involves acknowledging and understanding “what is” rather than focusing on “should” and “what ifs.”
It has been hard to share my cancer journey because I do not know where to start. When I was first diagnosed, I would read the cancer journeys of others and it gave me hope and inspiration. I need to pass it forward. I want to give hope, love and faith to all cancers patients that are in the fight. I am a 4X lymphoma survivor! Yeah that’s right, four times! Crazy! I was first diagnosed in 2017 after I got married and turned 30 years old. I was so looking forward to buying a house and sta...
With studies showing between 30-60% of blood cancer patients at risk of death if infected with the COVID-19 virus compared to patients who are cancer-free, The Leukemia & Lymphoma Society (LLS) announced today it is launching the first clinical trial dedicated solely to this most vulnerable population. This trial (LLS Protocol Number: BAML-16-001-COV1) will test a drug called acalabrutinib in patients diagnosed with acute myeloid leukemia, acute lymphoblastic leukemia, myelodysplastic ...
In honor of Blood Cancer Awareness Month, Dr. Gwen Nichols reflects on our vital work to support blood cancer patients and their families. As Chief Medical Officer of The Leukemia & Lymphoma Society (LLS), I often speak with patients and survivors about adjusting to their new normal after a cancer diagnosis or treatment. But finding a new normal looks very different in a world where a global pandemic has impacted every aspect of cancer care and daily life as we know it. COVID-19 is res...
I was diagnosed in December of 2017 with stage 4 Mantle Cell Lymphoma. After many tests, I started treatment on Jan 22. 2018. My treatment consisted of chemotherapy every 30 days-Rituxan, Bendeka, and Neulasta. I was prepared for the worst, expecting sickness, pain and all the other side effects that I heard about. By the grace of God, the only bad experience I had was after the first Neulasta treatment. The next day I felt like I had the worst case of flu in the world; aches, pain, nau...
This March was both my 27th birthday and my one-year "birth" day from when I received CAR-T immunotherapy. I had relapsed twice at that point and could hardly handle more chemotherapy. Now just over one year later, I remain in remission and feel incredibly lucky. I was first diagnosed with primary mediastinal large B-cell lymphoma in January 2018, after a month of experiencing chest pain. I had just finished my first semester of my Master's degree and then took a medical leave of absence ...
Some promising news to kick off Blood Cancer Awareness Month – on September 1, 2020, the U.S. Food and Drug Administration approved a new oral maintenance treatment for certain adult patients with acute myeloid leukemia (AML). CC-486 (Onureg®) is now approved for the continued treatment of adult patients with AML who achieved first complete remission (CR) or CR with incomplete blood count recovery (Cri) following intensive induction chemotherapy and who are not able to undergo intensive...
Living With and Managing Pediatric Cancer A Virtual Education Program (CT-HV) September 9, 2020 6:30PM – 8:00PM (ET) https://na.eventscloud.com/livingwith CLL Clinical Trials: Detailing Therapies & Trends A Virtual Education Program (Mid-Atlantic) September 10, 2020 4:00PM – 5:15PM (ET) https://na.eventscloud.com/563910 National Blood Cancer Conference 2020 Online/Virtual Interactive Conference September 12, 2020 11:30AM - 2:45PM (ET) http://www.lls.org/NationalBCC20...
430,000 people – it’s a huge number. It’s the population of Minneapolis. Nine straight days of sell-out crowds at Yankee Stadium. Nearly the entire enrollment of the Southeastern Conference. And it’s the number of people who, in the last six weeks, have become newly eligible for Medicaid, thanks to successful ballot initiatives this summer in Oklahoma and Missouri. LLS, our staff, and our volunteers are proud to have played a role in this major win for patients. Those victories cou...
The Association of Oncology Social Work recently held its annual meeting in which recognition of social work excellence was provided through several awards. One of these awards, LLS Hematology-Oncology Lifetime Achievement Award, honors an oncology social worker who has exhibited leadership and support for blood cancers patients and has had ongoing involvement with The Leukemia & Lymphoma Society throughout their career. This year, LLS is proud to announce the Lifetime Achievement Awa...
LLS celebrates its online Community members, now over 15,000 strong. LLS Community launched in 2016 to honor Michael Garil, who was diagnosed with acute lymphoblastic leukemia in 1974 at the age of 7. Throughout his life, Michael dedicated himself to openly sharing his experiences in the hopes of helping others. To continue what Michael started, his parents Ethel and Bernard Garil generously supported the creation of LLS Community in his memory. During the past four years, LLS Community ...
